[Federal Register Volume 72, Number 153 (Thursday, August 9, 2007)]
[Notices]
[Pages 44860-44861]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E7-15499]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Application

    Pursuant to Sec.  1301.33(a), Title 21 of the Code of Federal 
Regulations (CFR), this is notice that on June 29, 2007, Chattem 
Chemicals, Inc., 3801 St. Elmo Avenue, Building 18, Chattanooga, 
Tennessee 37409, made application by letter to the Drug Enforcement 
Administration (DEA) to be registered as a bulk manufacturer of the 
following

[[Page 44861]]

basic classes of controlled substances listed in schedule II:

------------------------------------------------------------------------
                    Drug                               Schedule
------------------------------------------------------------------------
Lisdexamfetamine (1205)....................  II
Remifentanil (9739)........................  II
------------------------------------------------------------------------

    The company plans to manufacture the listed controlled substances 
in bulk for sale to its customers.
    Any other such applicant and any person who is presently registered 
with DEA to manufacture such substances may file comments or objections 
to the issuance of the proposed registration pursuant to 21 CFR 
1301.33(a). Any such comments or objections being sent via regular mail 
should be addressed, in quintuplicate, to the Drug Enforcement 
Administration, Office of Diversion Control, Federal Register 
Representative (ODL), Washington, DC 20537; or any being sent via 
express mail should be sent to the Drug Enforcement Administration, 
Office of Diversion Control, Federal Register Representative (ODL), 
2401 Jefferson-Davis Highway, Alexandria, Virginia 22301; and must be 
filed no later than October 9, 2007.

    Dated: July 31, 2007.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. E7-15499 Filed 8-8-07; 8:45 am]
BILLING CODE 4410-09-P